zoledronic acid

Bone drug zoledronic acid may help prevent spread of early lung ...

http://www.eurekalert.org/rss/business.xml  Thu, 02/24/2011 - 23:00

(European Society for Medical Oncology) A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.


 

After-Hours Movers 7/7: AMGN, RT, ALKS, SHLM Higher; NEXM, XNPT,...

StreetInsider.com News Articles  Tue, 07/07/2009 - 16:05

NexMed, Inc. (Nasdaq: NEXM) 64.1% LOWER; announced the mutual decision with Novartis (NYSE: NVS) to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus.

NexMed entered into the exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM100060.